Faris Naji

's-hertogenbosch, NB, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors.

Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors.

Journal: Oncotarget
Published: June 06, 2022

KRSA: An R package and R Shiny web application for an end-to-end upstream kinase analysis of kinome array data.

KRSA: An R package and R Shiny web application for an end-to-end upstream kinase analysis of kinome array data.

Journal: PloS one
Published: May 21, 2021

Kinomics platform using GBM tissue identifies BTK as being associated with higher patient survival.

Kinomics platform using GBM tissue identifies BTK as being associated with higher patient survival.

Journal: Life science alliance
Published: February 12, 2021

Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia.

Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia.

Journal: International journal of molecular sciences
Published: September 30, 2020

Kinome Array Profiling of Patient-Derived Pancreatic Ductal Adenocarcinoma Identifies Differentially Active Protein Tyrosine Kinases.

Kinome Array Profiling of Patient-Derived Pancreatic Ductal Adenocarcinoma Identifies Differentially Active Protein Tyrosine Kinases.

Journal: International journal of molecular sciences
Published: September 29, 2020

Differential escape mechanisms in cetuximab-resistant head and neck cancer cells.

Differential escape mechanisms in cetuximab-resistant head and neck cancer cells.

Journal: Biochemical and biophysical research communications
Published: May 16, 2019

Clinical and kinomic analysis identifies peripheral blood mononuclear cells as a potential pharmacodynamic biomarker in metastatic renal cell carcinoma patients treated with sunitinib.

Clinical and kinomic analysis identifies peripheral blood mononuclear cells as a potential pharmacodynamic biomarker in metastatic renal cell carcinoma patients treated with sunitinib.

Journal: Oncotarget
Published: April 14, 2016

Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology.

Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology.

Journal: Journal of Alzheimer's disease : JAD
Published: November 01, 2015
Showing 1-8 of 8

Last Updated: 09/26/2026